4.7 Article

Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity

Mahesh P. Gupta et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity

Chinmay M. Trivedi et al.

NATURE MEDICINE (2007)

Article Chemistry, Medicinal

A series of novel, potent, and selective histone deacetylase inhibitors

Philip Jones et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Article Cardiac & Cardiovascular Systems

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy

Yongli Kong et al.

CIRCULATION (2006)

Article Medicine, Research & Experimental

Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

Cinzia Perrino et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Review Cardiac & Cardiovascular Systems

Control of cardiac growth by histone acetylation/deacetylation

J Backs et al.

CIRCULATION RESEARCH (2006)

Review Pharmacology & Pharmacy

Rational development of histone deacetylase inhibitors as anticancer agents: A review

MR Acharya et al.

MOLECULAR PHARMACOLOGY (2005)

Article Biochemistry & Molecular Biology

Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis

IV Gregoretti et al.

JOURNAL OF MOLECULAR BIOLOGY (2004)

Review Genetics & Heredity

Cardiac histone acetylation - therapeutic opportunities abound

TA McKinsey et al.

TRENDS IN GENETICS (2004)

Article Biochemistry & Molecular Biology

Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases

MH Brush et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors

CL Antos et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Review Genetics & Heredity

Class II histone deacetylases: versatile regulators

E Verdin et al.

TRENDS IN GENETICS (2003)

Review Physiology

Cardiac hypertrophy: The good, the bad and the ugly

N Frey et al.

ANNUAL REVIEW OF PHYSIOLOGY (2003)

Article Multidisciplinary Sciences

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

G Condorelli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Multidisciplinary Sciences

HDAC6 is a microtubule-associated deacetylase

C Hubbert et al.

NATURE (2002)

Article Medicine, General & Internal

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

BD Lowes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Multidisciplinary Sciences

Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo

CL Antos et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Review Biochemistry & Molecular Biology

Structure of histone deacetylases: Insights into substrate recognition and catalysis

R Marmorstein

STRUCTURE (2001)

Article Multidisciplinary Sciences

Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure

VB Harding et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo

BA Rothermel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Oncology

The human histone deacetylase family

SG Gray et al.

EXPERIMENTAL CELL RESEARCH (2001)

Review Oncology

Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells

PA Marks et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)

Article Cardiac & Cardiovascular Systems

Cardiac hypertrophy is not a required compensatory response to short-term pressure overload

JA Hill et al.

CIRCULATION (2000)